Quest Diagnostics vs Lifestance Health
Quest Diagnostics (DGX) and Lifestance Health (LFST) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $28.4B
- Last close
- $258.28
- 12 months
- +37.7%
- Market value
- $5.25B
- Last close
- $13.82
- 12 months
- +123.6%
At a glance
- By market value, Quest Diagnostics ($28.4B) is about 5.4 times Lifestance Health ($5.3B).
- Over the last 12 months Quest Diagnostics's share price moved +37.7% and Lifestance Health's +123.6%; against the S&P 500 that is +32.0 points and +117.9 points.
- In their last fiscal years Quest Diagnostics kept 9.0% of revenue as net income and Lifestance Health 0.7%.
- In the last 90 days insiders reported 0 open-market purchases at Quest Diagnostics and 0 at Lifestance Health; members of Congress disclosed 0 trades in Quest Diagnostics and 0 in Lifestance Health.
- Next results: Quest Diagnostics Feb 8, 2027, Lifestance Health not announced.
Share prices on one chart
Quest Diagnostics and Lifestance Health, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Quest Diagnostics DGXNYSE · Health Care Services | Lifestance Health LFSTNASDAQ · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $28.4B | $5.25B |
| Revenue, last fiscal year | $11B | $1.42B |
| Net income, last fiscal year | $992M | $9.66M |
| Net marginNet income as a share of revenue | 9.0% | 0.7% |
| Free cash flow | $1.36B | $110M |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Quest Diagnostics against
Common questions
How is Quest Diagnostics different from Lifestance Health?
Quest Diagnostics (DGX) is in Health Care Services on NYSE, with $11B of revenue in its last fiscal year and a net margin of 9.0%. Lifestance Health (LFST) is in Health Care Services on NASDAQ, with $1.42B of revenue in its last fiscal year and a net margin of 0.7%. Both are in the same industry, so the gap is mostly one of size and profitability. The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Quest Diagnostics and Lifestance Health compare in size?
Quest Diagnostics has the larger market value: Quest Diagnostics $28.4B and Lifestance Health $5.25B, at the last close.
Whose share price rose more over the last 12 months, DGX or LFST?
Over the last 12 months Quest Diagnostics moved +37.7% and Lifestance Health +123.6%. Past price moves say nothing about the future.
Which has had more insider buying, Quest Diagnostics or Lifestance Health?
Since 2006, Quest Diagnostics insiders reported 8 open-market purchases against 5 for Lifestance Health. These are counts of what was filed, not a view on either stock.
Do members of Congress trade DGX or LFST?
In the last 12 months, members of Congress disclosed 8 trades in Quest Diagnostics (DGX) and 0 in Lifestance Health (LFST).
When did insiders last buy DGX and LFST?
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Quest Diagnostics pageLifestance Health pageRare insider trades this weekAll comparisons
https://oqro.io/compare/dgx-vs-lfst




